SOSV

How Inbolt Is Teaching Blind Robots to See SOSV portfolio company Inbolt, an alum of the SOSV HAX program, was profiled by The New York Times for beating a limitation that has slowed industrial automation for decades: most robots can't see. At a Stellanti

The AI buildout has a bottleneck, and it isn't chips. It's power. Join us for the next Deep Tech LIVE with Dr. Jesse Jenkins and SOSV HAX's Duncan Turner. REGISTER IN-PERSON REGISTER VIRTUAL Interconnection queues stretch for years, deals get signed under

From the critical minerals pulled out of the ground to the on-demand manufacturing of chips, drones, batteries, and even apparel, a new industrial stack is being built in America - one mineral, one machine, one megawatt at a time. Join us for SOSV HAX's D

SOSV portfolio company, Princeton Critical Minerals, spoke to Axios following the announcement of its $16 million raise in combined equity and non-dilutive funding, including an $11 million Series A led by SOSV, plus grants from the National Science Found

Climate Week NYC is one of the world's leading global climate gatherings and it's just around the corner! This summer's heat waves and wild fires are a potent reminder that climate change is an ever more tangible and uncomfortable reality. The good news i

Nukoko founders Kit Tomlinson, David Salt and Ross Newton Credit: Nukoko Everyone says it: Food tech startups are slow, expensive, and risky. Tastes are fickle. If you build it, they may NOT come. Or so we've been told. This is the true story of three fou

SOSV portfolio company, Capra Biosciences, recently spoke with SynBioBeta about their expanded $17 million award from the U.S. Department of Health and Human Services' Center for Industrial Base Management and Supply Chain, part of ASPR. The funding will

Last week, 571 therapeutics founders and investors joined SOSV's virtual matchmaking event, generating over 1,000 meetings during the week. A few patterns stood out. Strong alignment on disease areas The five most common areas were the same for both inves

Incremental biology is giving way to nanobiology-an era where we engineer life at the molecular scale. Today, the frontiers of human health look less like traditional pharmacology and more like advanced logistics: designing nanoscopic delivery systems, bi

At our latest SOSV Deep Tech Live, Dr. Susan Schofer, Partner & Chief Science Officer at SOSV HAX, sat down with semiconductor legend Dr. Rick Gottscho, Retired Head of Products and CTO of Lam Research, to unpack the past, present, and highly disruptive f